Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: "Pharmacist's Patients Protection Act of 1996"

Executive Summary

"Pharmacist's Patients Protection Act of 1996": HR 3260, which would amend the funding section (906) of the FD&C Act to deny funding for FDA's "MedGuide" proposal, is introduced April 18 by Rep. Crapo (R-Idaho). It is understood that the Crapo bill will be presented as an amendment to Rep. Burr's (R-N.C.) FDA reform bill (HR 3194) during mark-up. Crapo worked with the National Association of Retail Druggists in drafting the bill ("The Pink Sheet" April 15, T&G-11)...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS028025

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel